NEWS

Aristocrat ‘could now target Playtech unit’

SYDNEY: Aristocrat could line up to buy Playtech’s business-to-business unit separately, according to ... read more

Biotechs gain big boost from patent box legislation proposal

MELBOURNE: Australian biotech heavyweights including Cochlear and ResMed are cheering the introduction of ... read more

Prota cracks $20m raising for its allergy treatment

MELBOURNE: Australian biotech Prota Therapeutics is chasing $20 million to prepare Phase 3 ... read more

Terms out for Microba IPO and investors are not happy

BRISBANE: Gut health biotech Microba’s brokers have blasted the terms of its $30 ... read more